Dashboard
Manage Tickers

ENTA ENANTA PHARMACEUTICALS INC

Nasdaq enanta.com


$ 10.79 $ -0.10 (-0.92 %)    

Friday, 31-Oct-2025 12:08:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.50 $ -4.50 (-0.71 %)
DIA $ 474.96 $ -0.93 (-0.2 %)
SPY $ 681.49 $ -3.53 (-0.52 %)
TLT $ 90.33 $ -0.22 (-0.25 %)
GLD $ 367.76 $ -2.71 (-0.73 %)
$ 10.86
$ 10.89
$ 10.75 x 1
$ 10.83 x 102
$ 10.76 - $ 11.00
$ 4.09 - $ 15.34
675,538
na
232.16M
$ 1.06
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 02-12-2025 12-31-2024 10-Q
4 11-27-2024 09-30-2024 10-K
5 08-07-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 02-08-2024 12-31-2023 10-Q
8 11-22-2023 09-30-2023 10-K
9 08-08-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 02-08-2023 12-31-2022 10-Q
12 11-23-2022 09-30-2022 10-K
13 08-08-2022 06-30-2022 10-Q
14 05-09-2022 03-31-2022 10-Q
15 02-10-2022 12-31-2021 10-Q
16 11-24-2021 09-30-2021 10-K
17 08-09-2021 06-30-2021 10-Q
18 05-10-2021 03-31-2021 10-Q
19 02-09-2021 12-31-2020 10-Q
20 11-25-2020 09-30-2020 10-K
21 08-10-2020 06-30-2020 10-Q
22 05-11-2020 03-31-2020 10-Q
23 02-10-2020 12-31-2019 10-Q
24 11-27-2019 09-30-2019 10-K
25 08-09-2019 06-30-2019 10-Q
26 05-10-2019 03-31-2019 10-Q
27 02-08-2019 12-31-2018 10-Q
28 11-29-2018 09-30-2018 10-K
29 08-09-2018 06-30-2018 10-Q
30 05-10-2018 03-31-2018 10-Q
31 02-09-2018 12-31-2017 10-Q
32 12-11-2017 09-30-2017 10-K
33 08-09-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 02-09-2017 12-31-2016 10-Q
36 12-09-2016 09-30-2016 10-K
37 08-09-2016 06-30-2016 10-Q
38 05-10-2016 03-31-2016 10-Q
39 02-09-2016 12-31-2015 10-Q
40 12-11-2015 09-30-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

enanta-pharmaceuticals-highlights-promising-zelicapavir-pediatric-results-and-edp-323-post-exposure-prophylaxis-data-for-rsv-at-idweek-2025
Enanta Pharmaceuticals Highlights Promisin...
10/20/2025 11:04:06

Zelicapavir Results in Shortened Symptom Duration in Pediatric PatientsEDP-323 is Highly Effective in a Post-Exposure Prophylax...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/16/2025 21:06:04

enanta-pharmaceuticals-to-showcase-rsv-drug-data-at-idweek-2025-highlighting-two-oral-once-daily-treatments
Enanta Pharmaceuticals to Showcase RSV Dru...
10/07/2025 11:14:53

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating novel, small molecule ...

jefferies-upgrades-enanta-pharma-to-buy-raises-price-target-to-20
Jefferies Upgrades Enanta Pharma to Buy, R...
10/01/2025 16:27:48

Jefferies analyst Akash Tewari upgrades Enanta Pharma (NASDAQ:ENTA) from Hold to Buy and raises the price target from $14 to...

cal-maine-foods-posts-downbeat-earnings-joins-enanta-pharmaceuticals-aar-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
Cal-Maine Foods Posts Downbeat Earnings, J...
10/01/2025 12:16:06

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/01/2025 12:09:24

why-ryvyl-shares-are-trading-higher-by-97-here-are-20-stocks-moving-premarket
Why Ryvyl Shares Are Trading Higher By 97%...
10/01/2025 09:45:27

reported-earlier-enanta-pharmaceuticals-prices-upsized-public-offering-of-65m-common-shares-at-1000-each-targeting-65m-gross-proceeds
Reported Earlier, Enanta Pharmaceuticals P...
10/01/2025 05:57:38

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/30/2025 21:06:48

enanta-pharma-commences-50m-public-offering-with-option-to-sell-additional-75m-in-common-stock
Enanta Pharma Commences $50M Public Offeri...
09/30/2025 20:13:18

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs f...

westpark-capital-maintains-buy-on-enanta-pharma-raises-price-target-to-28
WestPark Capital Maintains Buy on Enanta P...
09/30/2025 12:01:09

WestPark Capital analyst Ed Arce maintains Enanta Pharma (NASDAQ:ENTA) with a Buy and raises the price target from $24 to $28.

Core News & Articles
10 Health Care Stocks With Whale Alerts In...
09/29/2025 17:35:29

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and...

enantas-rsv-pill-shows-promise-in-cutting-recovery-time-for-high-risk-adults
Enanta's RSV Pill Shows Promise In Cutting...
09/29/2025 17:28:46

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) on Monday released topline data from RSVHR Phase 2b study of zelicapavir in outpati...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
09/29/2025 17:06:50

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands...

enanta-pharma-reports-topline-data-from-rsvhr-phase-2b-study-to-evaluate-efficacy-and-safety-of-zelicapavir-in-outpatient-adults-with-acute-rsv-infection
Enanta Pharma Reports Topline Data From RS...
09/29/2025 10:33:28

6.7-Day Improvement in Time to Complete Resolution of All RSV Symptoms for Patients with Chronic Obstructive Pulmonary Disease ...

why-merus-shares-are-trading-higher-by-38-here-are-20-stocks-moving-premarket
Why Merus Shares Are Trading Higher By 38%...
09/29/2025 09:07:53

Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announced plans to acquire Merus fo...

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
09/26/2025 21:06:04

Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of t...

enanta-pharma-to-share-topline-results-from-rsvhr-phase-2b-study-evaluating-zelicapavir-for-treatment-of-rsv-in-high-risk-adults-on-sept-29
Enanta Pharma To Share Topline Results Fro...
09/26/2025 20:02:49

Conference Call and Webcast to Discuss Data on Monday, September 29at 8:30 a.m.

4-analysts-have-this-to-say-about-enanta-pharma
4 Analysts Have This To Say About Enanta P...
09/15/2025 14:01:45

evercore-isi-group-maintains-outperform-on-enanta-pharma-lowers-price-target-to-12
Evercore ISI Group Maintains Outperform on...
09/15/2025 13:50:36

Evercore ISI Group analyst Liisa Bayko maintains Enanta Pharma (NASDAQ:ENTA) with a Outperform and lowers the price target f...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION